The clinical-stage biotech company that develops stem cell treatments posted revenue of $1 million in the period, which also fell short of Street ...
News
- Fate Therapeutics: 3Q Earnings Snapshot
- Cerus: 3Q Earnings Snapshot
The biomedical products company posted revenue of $15.4 million in the period. Cerus expects full-year revenue in the range of $58 million to $60 ...
- Bluebird: 3Q Earnings Snapshot
The biotechnology company posted revenue of $11.5 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected ...
- The Coffee Lover's Guide to San Antonio
In the last decade, Local Coffee has made its mark on San Antonio and ... who still works full-time at the Texas Biomedical Research Institute, started ...
- AP FACT CHECK: Ad on Tina Smith's investments is misleading
Johnson & Johnson is a massive company that recorded $76.5 billion in sales last year from its three divisions: biotech drugs, medical devices and ...